3 results
Approved WMORecruiting
To study the effects of PF-06835919 on fructose tolerance and intrahepatic lipid content in patients with HFI.
Approved WMOCompleted
Primary objective:The primary objective of this study is to assess the time to painful VOC resolution, measured from the first dose of sevuparine given to achievement of crises resolution, as compared to placebo. Secondary objectives: The secondary…
Approved WMORecruiting
To demonstrate safety and efficacy of Firehawk® rapamycin eluting stent system in comparison to currently approved 2nd generation DESin wide clinical use.